文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

急诊监护研究中的研究监查:复苏结局联盟持续胸外按压试验的经验

Study Monitoring in Emergency Care Trials: Lessons from the Resuscitation Outcomes Consortium Continuous Chest Compressions Trial.
PubMed 文献 · Acad Emerg Med · 2019-06-23
一句话结论在ROC-CCC试验中,研究监查委员会通过月度绩效报告使55家机构中的78%改进绩效并继续参与,12家被暂停,数据监查获得高质量CPR(平均胸外按压分数0.80)。

该研究考察了ROC-CCC试验中研究监查委员会(SMC)的运作与结果,该试验比较持续与间断胸外按压对院外心脏骤停生存的影响。SMC设定试验绩效基准,包括干预依从性、CPR过程数据可获取性和数据及时完成,并向研究者发送月度绩效报告。在113家入组机构、共2367个机构-月的监查中,178个机构-月(7.5%)处于察看期,55家机构至少一次被察看,其中78%改进绩效并获准继续参与,12家被暂停。数据监查获得平均胸外按压分数0.80、87%的CPR过程可获取性及及时数据完成(院前数据第75和95百分位分别为22和57天,医院数据分别为58和118天)。

要点

  • ROC-CCC试验中SMC对113家入组机构共2367个机构-月进行监查,178个机构-月(7.5%)处于察看期。
  • 55家机构至少一次被察看,其中78%改进绩效并获准继续参与试验,12家机构被暂停。
  • 数据监查结果:平均胸外按压分数0.80,CPR过程数据可获取率87%。
  • 数据完成及时性:院前数据第75和95百分位为22和57天,医院数据为58和118天。
  • 研究监查程序可能对确保急性期临床试验的执行质量起重要作用。

适用人群与场景

  • 国际性院外心脏骤停试验(ROC-CCC)的入组机构,包括113家入组机构,主要分析人群共23711例受试者。

诊断标准与关键阈值

  • SMC定义的试验绩效基准包括:干预依从性、心肺复苏(CPR)过程数据可获取性、数据及时完成。

处置流程与药物剂量

  • SMC向试验研究者发送月度绩效报告。
  • 对未达绩效基准的机构采取察看(probation)措施,持续改进者获准继续参与,否则暂停(suspension)。

研究设计与关键结果

  • 研究类型为对ROC-CCC试验中SMC运作的考察;主要分析人群共23711例受试者,来自113家入组机构,监查共2367个机构-月。
  • 178个机构-月(7.5%)处于察看期;55家机构至少一次被察看,其中78%改进绩效并获准继续参与,12家机构被暂停。
  • 数据监查获得平均胸外按压分数0.80、CPR过程数据可获取率87%。
  • 数据完成及时性:院前数据第75和95百分位分别为22天和57天,医院数据分别为58天和118天。

证据类型、等级与局限

  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,研究监查程序可能对确保急性期临床试验的执行质量起重要作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Clinical trial investigators often assemble internal study monitoring committees (SMCs) to measure individual or group adherence with trial performance benchmarks. We examined the processes and results of study monitoring in an international trial of out-of-hospital cardiac arrest.

METHODS: We studied SMC operations for the Resuscitation Outcomes Consortium (ROC) Continuous Chest Compressions (CCC) trial, which compared continuous with interrupted chest compressions upon survival after out-of-hospital cardiac arrest. The SMC defined trial performance benchmarks, which included compliance with the intervention, cardiopulmonary resuscitation (CPR) process data availability and timely data completion. Trial investigators received monthly performance reports. We determined rates of trial noncompliance and suspension from the trial.

RESULTS: ROC-CCC enrolled a total of 23,711 subjects in the primary analysis population. Across 113 enrolling agencies, the SMC monitored performance for a total 2,367 agency-months. Emergency medical services agencies were on probation for a total of 178 (7.5%) agency-months. Fifty-five agencies were placed on probation at least once, of which 78% improved their performance and were approved for continued participation in the trial. A total of 12 agencies were suspended from trial participation. Data monitoring resulted in high-quality CPR (mean chest compression fraction = 0.80), 87% CPR process availability and timely data completion (75th and 95th percentiles prehospital data = 22 and 57 days; hospital data = 58 and 118 days).

CONCLUSIONS: Study monitoring procedures may play an important role in ensuring the performance quality in acute care clinical trials.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Schmicker RH, Nichol G, Callaway CW, et al. Study Monitoring in Emergency Care Trials: Lessons from the Resuscitation Outcomes Consortium Continuous Chest Compressions Trial. Acad Emerg Med. 2019. PMID: 31148319. doi:10.1111/acem.13810

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。